Johnson et al v. Abbott Laboratories et al
Melodie Johnson |
Abbott Laboratories, Takeda Pharmaceuticals USA, Inc., Astrazeneca LP, Takeda Pharmaceutical Company Limited, Merck & Co., Inc., The Procter & Gamble Company, Astrazeneca Pharmaceuticals LP, Pfizer, Inc., The Procter & Gamble Manufacturing Company, Takeda Development Center Americas, Inc. and Takeda Pharmaceuticals America, Inc. |
1:2019cv04447 |
July 2, 2019 |
US District Court for the Northern District of Illinois |
Andrea R Wood |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1332 |
Both |
Docket Report
This docket was last retrieved on July 22, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
ELECTRONIC Acknowledgement of case transferred to the District of New Jersey [LIVE] as case 1:19-cv-15670, filed 07/22/2019. (jjr, ) |
Filing 17 TRANSFERRED to the New Jersey the electronic record. (nsf, ) |
Filing 16 CONDITIONAL TRANSFER ORDER from MDL Panel transferring case to New Jersey. (nsf, ) |
Civil Case Terminated pursuant to MDL 2789 Conditional Transfer Order filed 07/18/2019. (nsf, ) |
Filing 15 ATTORNEY Appearance for Defendant Pfizer, Inc. by Amy Michelle Rubenstein (Rubenstein, Amy) |
Filing 14 NOTICE of Motion by Heather Lynn Maly for presentment of motion to stay #13 before Honorable Andrea R. Wood on 8/1/2019 at 09:00 AM. (Maly, Heather) |
Filing 13 MOTION by Defendants Astrazeneca LP, Astrazeneca Pharmaceuticals LP, Merck & Co., Inc. to stay (Attachments: #1 Exhibit A, #2 Exhibit B)(Maly, Heather) |
Filing 12 MINUTE entry before the Honorable Andrea R. Wood: Initial status hearing set for 8/1/2019 at 9:00 AM. The parties are directed to meet and conduct a planning conference pursuant to Federal Rule of Civil Procedure 26(f). At least seven days before the initial status hearing, the parties shall file a joint written status report, not to exceed five pages in length. The initial status report shall provide the information described on the Court's website at www.ilnd.uscourts.gov under District Judges, Judge Andrea R. Wood, Initial Status Conference. Mailed notice (ef, ) |
Filing 11 NOTICE of Correction regarding #1 , #2 , #3 (ek, ) |
Filing 10 ATTORNEY Appearance for Defendants Astrazeneca LP, Astrazeneca Pharmaceuticals LP, Merck & Co., Inc. by Isaac J. Colunga (Colunga, Isaac) |
Filing 9 NOTICE TO THE PARTIES - The Court is participating in the Mandatory Initial Discovery Pilot (MIDP). The key features and deadlines are set forth in this Notice which includes a link to the (MIDP) Standing Order and a Checklist for use by the parties. In cases subject to the pilot, all parties must respond to the mandatory initial discovery requests set forth in the Standing Order before initiating any further discovery in this case. Please note: The discovery obligations in the Standing Order supersede the disclosures required by Rule 26(a)(1). Any party seeking affirmative relief must serve a copy of the following documents (Notice of Mandatory Initial Discovery and the Standing Order) on each new party when the Complaint, Counterclaim, Crossclaim, or Third-Party Complaint is served. (ek, ) |
Filing 8 MAILED Notice of Removal letter to counsel of record. (ek, ) |
Filing 7 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Astrazeneca LP, Astrazeneca Pharmaceuticals LP re notification of affiliates pursuant to local rule 3.2 #3 Amended (Maly, Heather) |
Filing 6 AMENDED notice of removal, #1 (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Maly, Heather) |
Filing 5 CIVIL Cover Sheet (Maly, Heather) |
Filing 4 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Merck & Co., Inc., D/B/A Merck, Sharp & Dohme Corporation (Maly, Heather) |
Filing 3 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Astrazeneca LP, Astrazeneca Pharmaceuticals LP (Maly, Heather) |
Filing 2 ATTORNEY Appearance for Defendants Astrazeneca LP, Astrazeneca Pharmaceuticals LP, Merck & Co., Inc., D/B/A Merck, Sharp & Dohme Corporation by Heather Lynn Maly (Maly, Heather) |
Filing 1 NOTICE of Removal from Circuit Court of Cook County, Illinois, case number (2019L006002) filed by Astrazeneca LP, Astrazeneca Pharmaceuticals LP, Merck & Co., Inc., D/B/A Merck, Sharp & Dohme Corporation Filing fee $ 400, receipt number 0752-15990272. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Civil Cover Sheet Civil Cover Sheet)(Maly, Heather) |
CASE ASSIGNED to the Honorable Andrea R. Wood. Designated as Magistrate Judge the Honorable Mary M. Rowland. Case assignment: Random assignment. (ec, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.